Consensus Cloud Solutions (CCSI) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
1 Feb, 2026Executive summary
Q2 2024 revenue was $87.5 million, down 5.7–6% year-over-year, mainly due to a 15.7–16% decline in SoHo, partially offset by 2.7–3% growth in Corporate revenue; all key metrics exceeded guidance.
Adjusted EBITDA rose 2.9% to $49.1 million, with margin improving to 56.1% from 51.4% year-over-year, driven by cost optimization.
Net income increased to $23.9 million, up 13.4% year-over-year, with EPS at $1.24 and adjusted EPS at $1.45, up 6.6%.
Free cash flow surged to $15.8 million, up nearly 300% year-over-year, and cash balance at quarter-end was $49–$49.2 million.
Strategic focus included cost reduction in SoHo marketing, corporate customer acquisition, cost structure optimization, and debt repurchase.
Financial highlights
Q2 2024 consolidated revenue: $87.5 million, down 5.7% year-over-year.
Adjusted EBITDA: $49.1 million (up 2.9% YoY), margin 56.1%.
Adjusted net income: $28.1 million (up 4.9% YoY); adjusted EPS: $1.45 (up 6.6% YoY).
Q2 free cash flow: $15.8 million, up 295–296% year-over-year; CapEx: $8.5–$8.6 million, down $1.6 million.
Net income margin increased to 27.3%, up 4.6 points year-over-year.
Outlook and guidance
Full-year 2024 revenue guidance reaffirmed at $338–$353 million; adjusted EBITDA at $182–$194 million.
Adjusted EPS guidance raised to $5.45–$5.55.
Q3 2024 revenue expected at $83.5–$87.5 million; adjusted EBITDA $44.5–$47.5 million; adjusted EPS $1.25–$1.35.
Latest events from Consensus Cloud Solutions
- Corporate growth, record cash flow, and debt reduction drive a strong 2026 outlook.CCSI
Q4 202510 Feb 2026 - Healthcare solutions and recurring revenue drive growth as FY2024 guidance is reaffirmed.CCSI
Goldman Sachs 45th Annual Global Healthcare Conference3 Feb 2026 - Healthcare interoperability, AI, and capital returns drive growth and margin improvement.CCSI
Jefferies Global Healthcare Conference31 Jan 2026 - Q3 revenue fell 3.1% but margin gains and debt reduction supported strong corporate growth.CCSI
Q3 202415 Jan 2026 - Record free cash flow, margin strength, and debt reduction highlight 2024 performance.CCSI
Q4 202423 Dec 2025 - Proxy covers director elections, auditor ratification, pay, ESG, and strong governance.CCSI
Proxy Filing2 Dec 2025 - Virtual meeting to vote on directors, auditor, and executive pay, all board-recommended.CCSI
Proxy Filing2 Dec 2025 - Q1 2025 revenue down 1.1%, Corporate growth offsets SoHo decline; guidance reaffirmed.CCSI
Q1 202525 Nov 2025 - Corporate revenue up 6.9% year-over-year, driving first total revenue growth in eight quarters.CCSI
Q2 202523 Nov 2025